Inhibition of STAT3 by Niclosamide Synergizes with Erlotinib against Head and Neck Cancer
Rui Li(Max Planck Institute of Immunobiology and Epigenetics), Xingming Deng(Emory University), Walter J. Curran(Piedmont Cancer Institute), Fadlo R. Khuri(American University of Beirut Medical Center), Zhuo G. Chen(Emory University), Zhongliang Hu(Central South University), Dong M. Shin(Emory University), Shuo You(Emory University), Gabriel Sica(Emory University)
Cited by 89
Related Papers
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
|The Lancet|2004|2.4k
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
|New England Journal of Medicine|2007|1.7k
Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
|Journal of Clinical Oncology|2013|1.1k
Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma
|New England Journal of Medicine|2016|1k